— Know what they know.
Not Investment Advice

KGET OTC

CaliPharms, Inc.
1W: +3900.0% 1M: +0.0% 3M: +0.0% YTD: +3900.0% 1Y: +3900.0% 3Y: +3900.0% 5Y: -80.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $474349 mcap · 11.86B float · 0.0015% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.5M
52W Range0.000001-0.00004
Volume680
Avg Volume174,131
Beta4.80
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOEric Watson
Employees4
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2013-12-24
33175 Temecula Parkway
Temecula, CA 92592
US
949-800-6645
About CaliPharms, Inc.

CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector. It rebranded to CaliPharms, Inc. in January 2017, having previously operated under the name Kleangas Energy Technologies, Inc. The corporate headquarters for CaliPharms, Inc. are located in Temecula, California.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms